Abstract
Elevated troponin levels are traditionally associated with acute myocardial infarction (AMI) and are widely used as a specific marker for the diagnosis of ischemic myocardial injury. However, recent studies have shown that elevated troponin levels can occur in several non-coronary conditions, requiring a more careful diagnostic approach to avoid misinterpretations and inadequate management. This study aimed to perform a systematic review of the literature on the non-coronary causes of elevated troponin levels, seeking to identify the main associated clinical conditions and discuss their prognostic value in different contexts. To this end, a systematic review of articles published between 2014 and 2024 was conducted using the PubMed, Scopus and Web of Science databases. The results revealed that conditions such as sepsis, pulmonary embolism (PE), chronic renal failure (CRF), chronic obstructive pulmonary disease (COPD) and tachyarrhythmias are the main non-coronary causes of elevated troponin levels. It is concluded that elevated troponin levels of non-coronary etiology are an important marker of severity and poor prognosis in several systemic conditions. Troponin levels should be interpreted carefully, taking into account the clinical context and underlying conditions of each patient.
References
ACOSTA, Giancarlo et al. Clinical determinants of myocardial injury, detectable and serial troponin levels among patients with hypertensive crisis. Cureus, v. 12, n. 1, 2020.
BOLAÑOS, Hans de Jesús Cruz et al. Mortality prediction with the use of inflammatory biomarkers in patients with septic shock. Medicina Crítica, v. 37, n. 3, p. 198-202, 2023.
CHEN, Yuqi et al. Diagnostic and prognostic value of biomarkers in acute myocardial infarction. Postgraduate Medical Journal, v. 95, n. 1122, p. 210-216, 2019.
COLLINSON, Paul O. et al. High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers. Clinical Chemistry and Laboratory Medicine (CCLM), v. 57, n. 5, p. 623-632, 2019.
DE LEMOS, J. A.; MURAKAMI, M.; PANTEGHINI, M. et al. Cardiac Troponins I and T: Molecular Markers for Early Diagnosis, Prognosis, and Accurate Triaging of Patients with Acute Myocardial Infarction. Molecular Diagnosis & Therapy, v. 32, p. 126-134, 2023.
GREASER, M. L.; GERGELY, J. Troponin: Structure, Function and Dysfunction. 2023.
HARADA, K.; POTTER, J. D. Familial Hypertrophic Cardiomyopathy and Troponin Mutations. Journal of Biological Chemistry, v. 279, p. 14488-14495, 2023. DOI: 10.1016/j.jbc.2023.
JATENE, Tannas et al. Atherosclerotic burden is the pathway to cardiovascular events. Brazilian Archives of Cardiology, v. 119, n. 3, p. 400-401, 2022.
LINDNER, Gregor et al. Non-acute myocardial infarction-related causes of elevated high-sensitive troponin T in the emergency room: a cross-sectional analysis. Internal and Emergency Medicine, v. 9, p. 335-339, 2014.
LONG, B. et al. An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction. American Journal of Emergency Medicine, 2019.
MARTÍNEZ-SANZ, R. et al. Troponin-I in hemodynamically established pulmonary thromboembolism: correlation with echocardiography and computed tomography angiography. Revista Española de Cardiología, v. 63, n. 7, p. 874-882, 2010. DOI: 10.1016/j.rce.2010.06.014.
MARTINS, A. F.; REDWOOD, C. S. Human cardiac troponin complex: structure and functions. Biochemistry (Moscow), v. 84, p. 200-210, 2023.
MARTINS, C. S. Troponin: Structure, Pathophysiology and Clinical Importance Beyond Myocardial Ischemia. Arq Med, v. 23, n. 6, p. 221-240, 2009.
MOTTA, A.; REDWOOD, C. S.; ZAMORA, M. Troponin structure and function: a view of recent progress. Journal of Muscle Research and Cell Motility, v. 36, p. 561-580, 2016.
O’DONNELL, D.; LAVENEZIANA, P. Physiology and Consequences of Lung Hyperinflation in COPD. European Respiratory Review, 2023.
ROBITAILLE, R.; LAFRANCE, J. P.; LEBLANC, M. Altered laboratory findings associated with end-stage renal disease. Seminars in Dialysis, v. 19, n. 5, p. 373-380, 2006.
SAGGIN, B. et al. Troponin I: Mechanisms and Applications in Myocardial Injury. Advances in Cardiac Research, v. 42, 2023. DOI: 10.1080/troponin.2023.
SHEYIN, Olusegun et al. The prognostic significance of troponin elevation in patients with sepsis: a meta-analysis. Heart & Lung, v. 44, n. 1, p. 75-81, 2015.
SMITH, J. A. et al. Troponin elevation and prognosis in pulmonary embolism: A multi-center cohort study. PubMed Central, v. 22, n. 5, p. 1120-1127, 2023. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081194/. Accessed on: 09 out. 2024.
SOEIRO, A. M. et al. Sensitive troponin I assay in patients with chest pain - Association with significant coronary lesions with or without renal failure. Brazilian Archives of Cardiology, 2017.
THYGESEN, Kristian et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal, v. 40, n. 3, p. 237-269, 2019.
THYGESEN, Kristian; JAFFE, Allan S. The gloomy long-term prognosis of patients with type 2 myocardial infarction or myocardial injury. Journal of the American College of Cardiology, v. 75, n. 9, p. 1014-1016, 2020.
TOLEDO, João Gabriel Assis et al. Evaluation of serum troponin I levels in patients with chronic kidney disease. Remecs Journal - Multidisciplinary Journal of Scientific Studies in Health, v. 7, n. 12, p. 32-42, 2022.
WAGNER, Björn; WEIDNER, Norbert; HUG, Andreas. Elevated high-sensitivity cardiac troponin T serum concentration in subjects with spinal cord injury. International Journal of Cardiology, v. 391, p. 131284, 2023.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Marcelo Flavio Gomes Jardim Filho